Ligand Pharmaceuticals Inc. Stock Prediction
AI-powered sentiment analysis and prediction trends for LGND, updated each market day.
LGND AI Sentiment
AI sees no strong directional signal for Ligand Pharmaceuticals Inc. stock over the next 10 market days.
Prediction date: Sept. 17, 2026
Exact scores are in the SharePreds app
The precise prediction score for this stock, with buy and sell targets and a stop loss, updated every market day.
About Ligand Pharmaceuticals Inc.
Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.
Sector
Exchange
Market Cap
$5,675,667,882
Cap Tier
Employees
47
Headquarters
SAN DIEGO, CA
Listed Since
Nov. 25, 1994
Website
LGND Sentiment Trend: Last 30 Predictions
Sentiment zones: Bullish · Neutral · Bearish
LGND Volatility
Ligand Pharmaceuticals Inc. has shown moderate price volatility over the last 5 trading days. Moderate volatility indicates normal market activity with typical price fluctuations.
